Skip to main content
    S

    Septerna, Inc. Common Stock (SEPN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $41.67
    -0.93 (-2.18%)

    Market Cap: $2.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Septerna, Inc. Common Stock (SEPN) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Septerna, Inc. Common Stock (SEPN) trades at 20.3x sales and 4.6x book value. Its forward P/E is 107.5x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E107.5x
    Price to sales20.3x
    Price to book4.6x
    PEGN/A

    As of Nov 17, 2026

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SEPN

    What is SEPN's forward P/E ratio?

    Septerna, Inc. Common Stock has a forward P/E ratio of 107.5x.

    Is SEPN stock overvalued?

    GNG's valuation label for SEPN is Fairly valued.

    What is SEPN's price to sales ratio?

    Septerna, Inc. Common Stock has a price to sales ratio of 20.3x.